Sun sinks 13% after reports of 2nd whistleblower letter

Sun complained that such access creates a "great asymmetry in the information circulating between analysts, investors and media, leading to intense speculation".
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology